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Abstract
The impact of stress on brain function is increasingly recognized. Various substances are released
in response to stress and can influence distinct neuronal circuits, but the functional advantages of
having such a diversity of stress mediators remain unclear. Individual neurotransmitter, neuropeptide
and steroid stress mediators have specific spatial and temporal niches, but these niches also overlap.
In addition, the effects of individual mediators on neuronal function and plasticity are integrated, and
emerging evidence suggests that there is crosstalk between them. Together, this results in the stress
instruments producing an orchestrated ‘symphony’ that enables fine-tuned responses to diverse
challenges.
Any actual or potential disturbance of an individual's environment — a ‘stressor’ — is
recognized or perceived by specific brain regions. The subjective state of sensing potentially
adverse changes in the environment is called ‘stress’ and leads to the release of molecules that
we here call ‘stress mediators’, which bind to receptor targets. Each of these mediators acts on
specific neuronal populations, resulting in unique downstream effects. Together, these effects
constitute the ‘stress response’, which enables the animal to adapt to the changing
environment1-4.
A perplexing aspect of the stress response is its complexity. Various stress mediators have been
described, including neurotransmitters (for example, noradrenaline and serotonin), peptides
(for example, corticotropin-releasing hormone (CRH), other members of the CRH family and
vasopressin) and steroid hormones (for example, cortisol in humans and corticosterone in
rodents). What is the reason for the existence of these multiple instruments? Is there not a
staggering degree of redundancy?
In this Perspective we initially discuss the characteristic spatial and temporal niches of key
stress mediators and provide emerging evidence that these niches overlap, affording
opportunities for interactions between mediators. We then highlight these interactions,
showing that the stress mediators act in concert. We argue that the diversity of the instruments
of stress, rather than being redundant, enables both optimal niches of action for each mediator
and interactions between the multiple mediators that orchestrate our brain's remarkable ability
to respond — and adapt — to a dynamic environment.
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A need for multiple mediators
Stress signifies a potential or actual threat that requires immediate changes in behaviour as
well as a modification of future behaviours. This is achieved through the modulation of
neuronal functioning at several levels of the CNS — levels that govern decision making,
learning and memory as well as hormonal, autonomic and emotional responses.
Different types of stressors require different responses (FIG. 1). The stressor type influences
the repertoire of neuronal populations that perceive a potential threat, as well as the neurons
and stress mediators that are engaged in the adaptive response. For example, physical stressors
such as blood loss, trauma and cold rapidly recruit the brainstem and hypothalamic regions1,
3, whereas psychological stressors such as social embarrassment, examinations or deadlines
primarily engage stress mediators in brain regions that subserve emotion (the amygdala and
the prefrontal cortex), learning and memory (the hippocampus) and decision making (the
prefrontal cortex)2,4,5. These are not segregated systems, because physical stressors often have
psychological aspects and vice versa.
The duration of the stressor also greatly influences the nature of the neuronal responses (FIG.
1). Acute stressors — for example, a rapidly approaching car — cause a rapid surge of
neurotransmission, neuronal activation and hormone release. This is followed by rapid return
to baseline levels, although the temporary activation of, for example, hippocampal and
hypothalamic neurons can ultimately lead to alterations in gene expression, which in turn
change subsequent neuronal responses. By contrast, chronic stress (typically defined as stress
that lasts a week or more) provokes sustained and/or progressive changes in the expression of
particular genes, structural alterations in neurons and changes in neuronal firing patterns
throughout the brain4,6. If such changes persist they can result in prolonged deviations from
the original functioning of the network3.
In addition, the characteristics of the responding brain determine the pattern and magnitude of
its response to a stressor. For example, the age of the animal influences the likelihood of a
signal being perceived as a stressor. It also influences the mediators that are released by
stressors, and their consequences3,7,8. For example, in rodents the molecular cascades that are
activated by stress in the hypothalamus9,10 and the hippocampus9,11 during adulthood differ
from those that are activated by stress in the infant and change again with aging7,12. In addition,
sex and genetic factors interact with life events, such as environmental enrichment or isolation,
to contribute to the diversity of the stressors and their impacts on an individual's brain.
Taken together, the large array of stress types and contexts, the genetic background, age and
sex of the stressed animal, as well as additional factors such as the point in the circadian rhythm
at which the stressful event takes place, create a rich and complex matrix of stressors. Each
unique stress situation requires an efficient response from numerous neuronal ensembles
throughout the CNS, a process that requires astute orchestration. This orchestration occurs
through the deployment of a repertoire of signalling molecules that can bring about the
temporal, spatial and context specificity of each individual stress response.
The diversity of stress mediators
Each stress mediator has its characteristic, ‘classic’ spatial and temporal domains. Below we
elaborate on the preferred spatial and temporal domains of the three main classes of stress
mediators and their individual contribution to the brain's stress response, as a preamble to
discussing their coordinated and interactive effects.
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Monoamines
Shortly after a stressful event, the release of monoamines, including noradrenaline, dopamine
and serotonin, is increased in specific neuronal populations13-16. This release is triggered by
brain circuits that are involved in the evaluation of the stressful event or is triggered indirectly,
through activation of the sympathetic nervous system1,5. The extent to which monoaminergic
systems are activated depends on many factors, including sex (for example, see REF. 17), the
time of day18 and the controllability or recurrence of the stressor13. For instance, activation
of raphe neurons (which produce serotonin) by shock exposure is only prominent when the
situation is uncontrollable13,19.
An enhanced release of monoamines after stress has been demonstrated in the hippocampus,
the amygdala, the prefrontal cortex and the nucleus accumbens, but it probably also takes place
in many other brain regions. However, the spatial distribution of the consequences of this
release depends also on the affinity and distribution of the monoamine receptor subtypes. Thus,
the combination of release site and receptor distribution and affinity provides a single stress
mediator with multiple spatial niches and different functions.
Stress-induced monoaminergic release and actions are fast. The release is generally induced
within minutes after the onset of the stressor (although region-specific differences exist20) and
seldom outlasts the duration of stressor exposure. Because monoamines generally act through
G protein-coupled receptors, which rapidly transfer their activation to downstream effectors,
the rapid rise in their level is quickly translated into altered functioning of neurons that express
these receptors.
Each monoamine contributes to specific behavioural aspects of the immediate response to the
stressor. For instance, increased levels of noradrenaline supposedly cause a shift from focused
processing of sensory information to a more general scanning of the environment, which may
provide better solutions for challenging conditions21. Dopamine, which is released during
moderate stress in the prefrontal cortex15, is thought to improve risk assessment and decision
strategies, and serotonin is instrumental in reducing post-stress anxiety22. Thus, monoamines
collectively promote important behavioural strategies that help the animal face and survive the
initial phase of a stressful event.
Neuropeptides
A number of neuropeptides are released by stress in specific neuronal populations and
contribute, often by activating multiple receptors, to the stress response11,23-26. Although
several of these stress-induced neuropeptides also act on peripheral receptors, we focus here
on their release and actions in the brain (TABLE 1). We confine the discussion to CRH and
vasopressin, although other peptides also mediate the effects of stress (orexin, ghrelin and
dynorphin) or counteract the stress response under specific contexts (oxytocin and
neuropeptide Y); additional peptides may regulate stress-related anxiety and dysphoria (for
example, galanin and substance P)26.
The canonical stress-activated neuropeptides include the CRH family and vasopressin, which
were first discovered in the hypothalamus24,25. CRH is released in response to stress from axon
terminals in the hypothalamic median eminence and acts on receptors in the pituitary24.
However, it is now known to also be expressed in neuronal populations in the amygdala24,26,
the hippocampus27 and the locus coeruleus28. Acting locally, the peptide exerts
neuromodulatory effects on target neurons within seconds after its release9,29,30, through two
G protein-coupled receptors, CRHR1 and CRHR2. CRH receptor occupancy influences
neuronal firing patterns9,29,30, gene expression11,26 and behaviour11,26,31-33, in a CRH dose-
and context-dependent manner. For example, release of CRH in the central nucleus of the
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amygdala during acute stress enhances memory consolidation34,35, and CRH released by
modest stress from hippocampal interneurons11,56 primes long-term potentiation36 and
improves memory37. By contrast, hippocampal release of large amounts of CRH in response
to severe stress38,39 can lead to hyperexcitability and seizures9,40 and to rapid loss of dendritic
spines in CA3 pyramidal cells39. CRH might also contribute to the structural changes in
hippocampal pyramidal cells that are provoked by chronic stress in both adult and developing
brains4,12,38. Other members of the CRH neuropeptide family, including the urocortins
(UCN1, 2 and 3), can bind to CRH receptors and act in distinct spatial domains. Thus, UCN1-
expressing neurons in the non-preganglionic Edinger–Westphal nucleus in the brainstem might
contribute to stress adaptation41.
In the hypothalamus, vasopressin interacts with CRH, promoting adrenocortico-tropic
hormone (ACTH) release from the pituitary in response to stress42. In the brain as a whole,
vasopressin acts on a wide array of neurons25,43 (TABLE 1): in the amygdala, the excitatory
actions of vasopressin, perhaps released from dendrites25, might contribute to the behavioural
stress response. Vasopressin might also modulate emotional memory and anxiety26.
The ‘activating’ actions of stress-induced CRH release are mediated primarily through binding
to CRHR1 (REFS 11,28,33,39), and the panoply of effects described above take place in a time
frame of seconds to minutes. In addition, studies in knockout mice suggest that CRHR2 binding
could exert effects at longer timescales and might function to shut down the stress
response31,32. The yin–yang functions of the two CRH receptors described above are
remarkably similar to the roles of the two corticosteroid receptors in mediating the early and
late effects of stress-induced corticosteroid release on neurons, as described below.
Steroids
Corticosteroids are secreted in a pulsatile and circadian fashion; stress triggers the release of
a large burst of corticosteroids that is superimposed on these rhythms44. Corticosteroids' access
to the brain is regulated by p-glycoproteins45 (however, see REF. 46), but the circadian pattern
and the stress-induced surge of corticosteroid levels are maintained in the brain (as was recently
demonstrated for the hippocampus47), allowing peripheral and central aspects of the stress
response to be integrated. All brain cells, including glia, are in principle exposed to
corticosteroid hormones — this contrasts with the spatially restricted pathways through which
monoamines and peptides exert their actions. Nevertheless, the sites in the brain where
corticosteroids are effective are restricted by the distribution of corticosteroid receptors.
In the mammalian brain, corticosteroid hormones primarily act through mineralocorticoid and
glucocorticoid receptors (MRs and GRs, respectively). MRs have a high affinity for
corticosteroids, so they are mostly occupied even when circulating corticosteroid levels are
low2. GRs have tenfold lower affinity; consequently, these receptors are only partially
occupied under basal conditions and become more occupied as corticosteroid levels increase
— for example, after stress. The two receptor types are differentially distributed in brain2. MRs
are highly expressed in neurons of the hippocampal formation and the lateral septum and
moderately expressed in subnuclei of the amygdala, the hypothalamic paraventricular nucleus
(PVN) and the locus coeruleus (FIG. 2). These regions define a circuit that is involved in the
cognitive, emotional and neuroendocrine processing of stressful events5. The distribution of
MRs thus overlaps with the distribution of CRHR1 (REF. 48). GRs are ubiquitously expressed
in the brain, but they are enriched in the hippocampus, the lateral septum and the PVN.
On binding of the hormone, corticosteroid receptors translocate to the nucleus, where they act
as regulators of gene transcription49. Therefore, steroid effects on neuronal function usually
require at least an hour to develop and last hours to days. In the hippocampus, MR activation
is a prerequisite for maintaining the ongoing information flow6, whereas activation of GRs —
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for example, after stress — causes a delayed suppression of neuronal excitability and synaptic
plasticity6,50, thus providing ‘negative-feedback regulation’ of behavioural aspects of the
stress response. Moreover, the suppression of synaptic plasticity by GRs — preventing new
input (not related to the earlier stressful situation) being encoded — could serve to protect the
stress-related information that is being consolidated after stress exposure. The slow, gene-
mediated consequences of GR activation depend on the life history; for example, adverse early-
life experiences or chronic stress in adulthood influence the number and the functioning of
GRs in the hippocampus6,51. Preliminary evidence suggests that in the basolateral amygdala
— unlike in the hippocampus — GR activation has lasting excitatory rather than suppressive
and normalizing effects on cell firing52. This illustrates the fact that one mediator acting
through one receptor type can have multiple effects, depending on the life history and cellular
context.
Acting in concert
As described above, each of the stress mediators has its own preferred spatial and temporal
domains of release and action. In principle, this allows the brain to deal with the entire range
of stress-provoked challenges — from immediate attention and strategy decisions that are
important for survival in the short term, to storage of information about the stressful situation
in case similar events are encountered in the future, which is advantageous in the long term.
However, the actions of the different stress mediators need to be orchestrated into a coordinated
stress response. This is enabled by overlap in the spatial and temporal niches of action of the
different mediators, which allows their actions to converge. In addition, there is increasing
evidence of direct interactions between the individual stress mediators.
Spatial niches
The fact that stress mediators are released only in certain areas and act only on those neurons
that express specific receptor subtypes was discussed above. Interestingly, different stress
mediator receptors are often expressed in ‘hot spots’ of the brain, such as the prefrontal cortex,
the amygdala, the hippocampus and the neurotransmitter synthesis areas (for example, the
dorsal raphe nucleus and the locus coeruleus) (FIG. 2), consistent with the concept of spatial
convergence of their actions53. The hot spots are strategic hubs that connect networks involved
in different aspects of the stress response. For example, neurons in the basolateral amygdala,
which are affected by noradrenaline, dopamine, CRH and corticosteroids, are instrumental for
sympathetic and neuroendocrine activation (through their output to the central amygdala), for
fine-tuning of arousal (through reciprocal connections with the locus coeruleus) and for the
processing of emotional and contextual aspects of stress (through the prefrontal cortex and
hippocampus). A second hot spot is the hippocampus, where individual neurons can express
receptors for corticosteroids, neuropeptides, monoamines (including serotonin and
noradrenaline) and opioids (FIG. 3), enabling the fine-tuning of neuronal firing in response to
a range of signals. Thus, although each stress mediator has a characteristic and unique spatial
domain, their functional contribution to the stress response is subject to integration with that
of other mediators, through convergence on interconnected networks (FIG. 2).
Here we carry this concept further, by proposing that both the spatial specificity and the
integration of the effects of distinct neuromodulators apply even at the level of a single neuron:
receptors that bind a given mediator are not only localized to specific neuronal populations but
also reside in selective subcellular neuronal domains, providing exquisite spatial resolution to
a mediator's effects. In other words, the site of release coupled with receptor localization
provides a fine-resolution spatial specificity regarding the actions of stress mediators. This is
illustrated in the hypothetical hippocampal pyramidal neuron shown in FIG. 3. In this neuron,
cytoplasmic receptors for corticosteroids — the MRs and GRs that, on binding, translocate to
the nucleus — are localized in the soma54, whereas the so-called membrane MRs are found in
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both the pre- and the postsynaptic membrane55. Similarly, CRHR1 is located in somata, on
dendrites38,39 and even in the postsynaptic density of dendritic spines56, whereas CRHR2
seems to reside on the axon initial segment (Y. Chen, personal communication). In addition,
monoamine receptors in hippocampal pyramidal cells reside on specific dendritic domains57,
58. It should be noted that the subcellular distribution of receptors is brain region-specific. For
example, dendritically located GRs have been found in the lateral amygdala59, and
presynaptically located CRHR1 has been found in locus coeruleus neurons28,60. This exquisite
spatial control of receptor localization ensures that the net sum of the effects of stress on the
activity of a single neuron will be a composite of the local effects of the different stress
mediators.
Temporal niches
Stress responses take place at timescales that span milliseconds to days. As discussed, the
different modulators have classically been considered to act at distinctive temporal profiles,
allowing both activation and termination of the stress response. In general, stress is assumed
to cause an initial, acute wave of effects that is carried by monoamines and peptides, starting
within seconds after the onset of a stressor61.
A second wave of ‘molecular’ effects of stress is typically discernible starting one to two hours
after stress exposure. These molecular effects are mediated primarily by GRs (acting as
transcription factors) and CRHR2 signalling and inhibit the lingering effects of the first wave
of stress-induced actions. This restores allostasis (that is, homeostatic control with a varying
setpoint (governed by demand), which is thought to achieve stability through change4) for both
cognitive and neuroendocrine functions.
Importantly, recent evidence concerning the full range of actions of the diverse stress mediators
has demonstrated that the mediators exert more subtle and context-specific actions outside their
classical temporal niches, and that these can be better considered within the framework of three
temporal (and functional) domains (BOX 1). For example, monoamines can induce synaptic
responses within seconds of stressor onset but also, through a different signalling cascade,
activate immediate early genes such as ARC; this extends their actions (for example, on memory
formation) to a more delayed time domain62. The consequences of such a delayed pathway
for stress responsiveness are particularly significant when the downstream targets include
genes that encode catecholamine-synthesizing enzymes63, as this would amplify the original
response. In another example, activation of CRHR1 can within seconds alter neuronal
afterhyper polarization29 and phosphorylate the transcription factor CRE-binding protein
(CREB)11. The downstream effects of CREB phosphorylation — that is, transcriptional
regulation of CRE (cAMP-responsive element)-containing genes, including c-FOS and CRH
— take place over hours. Depending on which genes' transcription is affected by CREB, this
contributes to the activation and/or resolution of the stress response.
Conversely, corticosteroids (which are classically thought to be slow-acting) also rapidly
change brain functioning through non-genomic pathways — for example, in the
hypothalamus64 and hippocampus65. In CA1 neurons, such rapid effects seem to be mediated
by the binding of corticosterone to MRs in the pre- and postsynaptic plasma membrane55. The
rapid MR activation facilitates increases in neuronal excitability by increasing the probability
of glutamate release65, the trafficking of glutamate receptor subunits66 and the suppression of
a K+ conductance55. Interestingly, the apparent affinity of this membrane MR for
corticosterone is a tenth that of the nuclear MR65. This low-affinity MR supposedly enables
the hippocampus to sense pulsatile corticosteroid fluctuations and, importantly, the surge in
corticosterone levels that occurs during the initial response to stress67. The rapid actions of
membrane MRs thus join those of other stress mediators like CRH and noradrenaline.
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Box 1
Temporal profiles of the orchestrated stress response
The stress response has classically been characterized by two temporal ‘waves’ of stress
mediator actions. The first includes rapid actions of noradrenaline, serotonin, dopamine and
corticotropin-releasing hormone (CRH) (the latter being predominantly mediated by CRH
receptor 1). These rapid actions of stress mediators promote vigilance, alertness, appraisal
of the situation and the choice of an optimal strategy to face the challenge. Because local
increases in stress mediator levels are short-lived, and because their actions typically quickly
subside, this first wave of events is not optimal for provoking the sustained, adaptive
components of a stress response, such as the consolidation of information associated with
(that is, the memory of) the stressor. This is instead accomplished through alterations of
gene expression and cell function, classically considered the second wave and attributed to
corticosteroids acting through glucocorticoid receptors.
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Recent work suggests that the temporal profile of the orchestrated stress response might fit
better into a framework of three temporal domains that denote distinct mechanisms of
operation of the stress mediators. For example, receptor activation by monoamines and
peptides can, in addition to having rapid synaptic effects, regulate transcription factors (such
as CRE-binding protein and AP1) within a seconds-to-minutes time frame3,11,63. This
rapid activation (or deactivation) of transcription factors can lead to sustained genomic
changes that help the organism to respond to stressors of different magnitudes and durations,
as well as to recurrent stress. Conversely, corticosterone, through non-genomic pathways
involving membrane-located mineralocorticoid receptors65, can act within minutes55.
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Taken together, these findings blur the classical distinction between rapid and delayed
responses to stress.
In view of the above, the temporal action profiles of stress mediators might best be
considered as a series of vectors commencing at the onset of stress, as shown in the figure.
Each hormone has a preferred temporal vector (shown as black arrows) that is associated
with a specific mode of cellular function (for example, synaptic or transcriptional). In
addition, most modulators exert stress-related actions through alternative molecular and
cellular pathways (shown as grey arrows), which take place in different temporal niches.
The length of each vector in the figure corresponds to the temporal domain denoted by the
concentric circles. Note that the non-genomic effects of corticosteroids develop slightly
later than the rapid aminergic and peptidergic actions, because it takes time to transport the
hormones from the adrenals (where they are secreted) to the brain. The combined actions
of each stress mediator make up its compound temporal and functional profile.
In summary, although each stress modulator contributes to the orchestrated stress response
through a main role with a defined temporal niche, it is now clear that most modulators play
additional, minor parts (BOX 1). These effects, which transcend the classical temporal niches,
enable further gradation and integration of responses to stressors of diverse nature, magnitude
and duration.
Direct interactions
Recently, several interactions between two or more stress mediators (and between stress
mediators and other neurotransmitters) have emerged, showing that the total contribution of
stress mediators to the stress response is more than just the sum of their individual effects (FIG.
4). For instance, the activity of noradrenergic neurons in the LC is modulated by interactions
between CRH, a stress mediator, and opioids and glutamate so as to achieve optimal
behavioural adaptation to a stressor28. Thus, as a result of stress exposure, LC noradrenergic
cell firing shifts from a moderate, tonic activity that is permissive of a superimposed phasic
activity to a high tonic firing that prevents phasic firing. A high ratio of phasic to tonic firing
is optimal for responding to sensory stimuli and is associated with focused attention and
maintenance of ongoing behaviour. By contrast, a low ratio, which results from stress exposure,
is thought to promote arousal, scanning of the environment and decision making, thus
increasing the chance of finding the optimal way to cope with the stressor21. Whereas glutamate
is instrumental in enhancing the phasic firing, the stress-induced shift towards high tonic firing
patterns is mediated by CRH projections from the central amygdala and by activation of
CRHR1 in the rostrolateral dendritic zone of the LC28. In turn, opiates inhibit LC tonic firing
by binding to κ- and μ-opioid receptors68. Thus, endogenous opioid release might be important
for resetting the level and mode of LC noradrenergic neuron activity after stress, helping to
terminate the central noradrenergic response to the stressor69.
In the projection areas of the LC, direct interactions between stress mediators also fine-tune
the activation and termination of noradrenergic signalling. Thus, in the hippocampal dentate
gyrus noradrenaline enhances excitability and synaptic plasticity, and this effect can be
augmented by rapidly acting corticosterone70. Behavioural observations in combination with
local pharmacological interventions have led to the conclusion that there is also synergy
between noradrenaline and glucocorticoids in the rodent basolateral amygdala71. This synergy
is thought to promote consolidation of emotional information72. However, when corticosterone
acts through the genomic pathway it can also suppress noradrenergic activity. In this slow
temporal domain, the steroid effectively suppresses the facilitation of information transfer by
noradrenaline6,70. This suppression of activity is supported by other slowly developing
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corticosteroid–monoamine interactions, including the steroid-induced enhancement of
hyperpolarizing effects that are mediated by the serotonin 1A receptor6.
There are additional examples of interactions between monoamines and the neuropeptide
CRH34,73. In the basolateral amygdala, CRH might interact with β-adrenergic activation
accomplished by endogenous monoamines34. Such interactions also take place in amygdala
projection areas. For instance, glutamate transmission in the pathway from the basolateral
amygdala to the medial prefrontal cortex — which is important for emotional processing and
decision making — is depressed by dopamine activation of D1 or D5 receptors, and CRH
(which on its own does not affect glutamate transmission) augments this depression73.
Importantly, this interaction is context dependent; for example, chronic cocaine administration
switches the synergistic actions of dopamine and CRH from suppressing to facilitating
glutamate transmission.
Note that interactions between stress mediators can take place in a single temporal domain (for
example, the interaction between CRH and glutamate) or between the classic temporal niches:
CRH ‘primes’ hippocampal neurons for subsequent excita-tory neurotransmission36, and fast-
acting monoamines might prime neurons for subsequent effects of stress-induced, slower-
acting mediators. The mechanisms by which these interactions take place require further study.
These examples illustrate that the spatial convergence and temporal overlap of the various
stress mediators enable multiple, direct and rapid interactions, resulting in synergistic actions
that orchestrate the acute stress response. Longer-lasting or delayed interactions between stress
mediators might promote the termination of the stress response.
Conclusions and future directions
The ability to change neuronal activity (and hence behaviour and cognition) both rapidly and
enduringly in response to threatening challenges is crucial for survival and has thus resulted
in a highly coordinated, complex and evolutionarily conserved stress-response system.
Because different challenges require distinct responses (for example, social decisions or flight)
that involve different sets of neuronal populations acting in concert or sequentially, the brain
has evolved a system that can produce such diverse alterations in neuronal activity. This system
consists of the stress mediators described in this Perspective, which not only occupy
characteristic niches of time, space and function, but also are exquisitely coordinated at
multiple levels to create an orchestrated stress-response symphony. This ‘stress neuro-
symphony’ provides the capacity to generate precise, focused alterations in neuronal activity
in response to stress signals. These alterations can range spatially from individual synapses up
to the whole animal and temporally from milliseconds to days.
Although our understanding of the individual instruments of this stress neuro-symphony has
increased substantially, more studies are needed to examine the additional actions of and
interactions between the stress mediators. New tools allow us to interfere with selected aspects
of a stress media-tor's signalling pathway in a site-specific and inducible manner, and therefore
let us examine the mediator's relevance to cellular activity in freely moving animals. Genome-
wide screening tools will enable better study of the full spectrum of each individual mediator's
actions, and of the coordinated effects of these mediators on stress-related programmes of gene
expression, which in turn influence behaviour in the long term. Ultimately, the roles that
interactions between stress mediators have in orchestrating human cognitive performance will
need to be investigated.
Finally, in view of the complexity of this stress neuro-symphony, it is not surprising that many
of its components can be deranged, leading to stress-related disorders including depression and
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anxiety. An improved understanding of how this system functions will enable better use of
current therapeutic interventions and the development of new clinically useful drugs.
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Figure 1. Different stressors require different responses
Many factors influence the pattern and magnitude of the response to stress, including the
duration of stress exposure (acute versus chronic), the type of stress (physical versus
psychological), the stress context (for example, time of day), the developmental stage of the
animal (newborn, adult or aged) and the animal's sex and genetic background. The panoply of
unique stress situations and neuronal populations that respond to them to affect neural and
behavioural plasticity on a timescale from seconds to years is not well served by a single
mediator — hence the need for multiple instruments, so that each combination of mediators
addresses the specific aspects of a stressor. The molecules that convey the stress signal to the
CNS and that contribute to the resulting functional changes in the CNS (stress mediators)
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include monoamines, neuropeptides and steroid hormones, examples of which are shown on
the right. Each mediator has a preferred activity domain in space and time.
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Figure 2. ‘Hot spots’ of receptors for key stress mediators
The β1-adrenoceptors for noradrenaline (B1Rs), CRH receptor 1 (CRHR1), CRHR2 and the
mineralocorticoid and glucocorticoid receptors (MRs and GRs, respectively) cluster in ‘hot
spots’ in the brain. These hot spots include the prefrontal cortex, specific amygdala nuclei, the
hippocampus (CA1, CA3 and the dentate gyrus (DG)), the paraventricular nucleus of the
hypothalamus (PVN), the dorsal raphe nuclei (DR) and the locus coeruleus (LC). In these areas,
receptors for at least two classes of mediators are highly expressed. The hot spots are strategic
hubs that connect networks involved in diverse aspects of the brain's stress response, including
learning and memory, decision making and hormonal, autonomic and emotional responses.
BLA, basolateral amygdala; BnST, bed nucleus of the stria terminalis; CeA, central amygdala;
CRH, corticotropin-releasing hormone; lat. septum, lateral septum; MA, medial amygdala;
NTS, nucleus tractus solitarii. Data from REFS 48,74–78.
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Figure 3. Subcellular localization of stress-mediator receptors
The actions of different stress mediators on a single neuron are orchestrated through the distinct
subcellular localization of the relevant receptors. This is illustrated in this cartoon of a
hypothetical pyramidal cell (which includes features that exist on either or both CA3 and CA1
principal cells). For example, corticotropin-releasing hormone receptor 1 (CRHR1) is located
in somata as well as on dendrites and dendritic spines3,39,48,56, whereas CRHR2 seems to
reside on the axon initial segment (Y. Chen, personal communication). In addition, monoamine
receptors that terminate on hippocampal pyramidal cells reside on specific dendritic
domains57,58. Note that the subcellular distribution patterns of each receptor might differ
between brain areas. For instance, glucocorticoid receptors (GRs) might be present on
postsynaptic (dendritic) domains in certain amygdala neurons59. 5-HT, 5-hydroxytryptamine;
MR, mineralocorticoid receptors; NA, noradrenaline.
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Figure 4. Direct interaction between different stress mediators
Noradrenaline (NA), corticotropin-releasing hormone (CRH), opioids and corticosterone
(CORT) interact in the locus coeruleus (LC) and its projection areas (including the
hippocampus and the amygdala) to orchestrate exquisite tuning of neuronal firing patterns in
response to stress. Exposure to stress shifts LC noradrenergic cell firing — which is normally
kept at a moderate level by glutamatergic input, here represented by the top left arrow — from
a moderate tonic activity to high tonic firing that prevents phasic firing. This shift is mediated
by CRH projections from the central amygdala on to CRH 1 receptors in the LC28. In turn,
LC noradrenergic cells project to the basolateral amygdala (BLA), hippocampal CA1 and the
dentate gyrus (DG). Here noradrenaline, released shortly after stress exposure, enhances
excitability, promoting the encoding of stress-related information. Glutamatergic output from
the BLA to the DG is thought to provide a means to ‘emotionally tag’ information processed
in the hippocampus, thus rendering it preference in storage71. The stress-induced enhancement
in activity in the LC, the BLA, the DG and CA1 (which in the DG is aided by rapid
corticosteroid actions; see main text) is gradually reversed, resulting in a return to the pre-stress
activity level. In the LC, the level of tonic firing is reduced by opiates that bind to κ- and μ-
opioid receptors68. In the BLA, the DG and CA1, these gradual normalizing effects are exerted
by corticosterone, presumably through glucocorticoid receptor-mediated gene-dependent
cascades6,70,79. The + signs indicate that the stress mediator enhances cell firing, whereas
the–signs indicate decreased cell activity. CeA, central amygdala.
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Table 1
Examples of stress-activated neuropeptides in the brain
Peptide Release location Receptor (and receptor location) Functions related to stress
CRH Central amygdala30,34,35 CRHR1 (basolateral amygdala)30,34,38,
78
CRHR2 (REF. 74)
Stress/emotional memory,
anxiety30,33,35,80
Termination of stress-
related anxiety31-33
Locus coeruleus28 CRHR1 (locus coeruleus)60,78 Interaction with
noradrenaline systems28
Hippocampal interneurons27,56 CRHR1 (pyramidal cells)11,39,48,56,78 Stress-related learning and
memory3,36,39
BnST26,81 CRHR1 (REFS 48,81) (nucleus
accumbens)81 and
CRHR2 (REFS 74,78,81)
Stress-related anxiety26,30
Urocortin Non-ganglionic
Edinger–Westphal nucleus41
CRHR1 and CRHR2 Interaction with CRH
systems during acute
and chronic stress
Urocortin 2
and 3
CRHR2 (REF. 41) Role in stress not
established
Vasopressin Hypothalamic dendrites
BnST and amygdala25,26,43
V1A (septum, hippocampus, BnST and
other
areas) and V1B
Stress-related and social
memory, and
perhaps emotionality25,26,
43
Orexin Lateral hypothalamic area26 OX1 and OX2 Stress-related energy and
sleep homeostasis
Dynorphin Hippocampal dendrites82 Several opioid receptors26 Stress-related dysphoria26
BnST, bed nucleus of the stria terminalis; CRH, corticotropin-releasing hormone; CRHR, CRH receptor; OX, orexin receptor; V1, vasopressin receptor
1.
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